Location: Brussels, Belgium

    CDDF-SIOPE-ENCCA-ITCC 3rd Paediatric Oncology Conference

    ‘Prioritisation in Paediatric Oncology Drug Development’

    5-6 February 2015, Vienna, Austria

    The CDDF (Cancer Drug Development Forum), previously known as BDA (Biotherapy Development Association), is organising in partnership with SIOPE, ENCCA and ITCC the 2015 edition of the high-level Paediatric Oncology Conference ‘Prioritisation in Paediatric Oncology Drug Development’. This is the third meeting of an ongoing series of biennial conferences aiming at promoting progress in the field of paediatric oncology drug development through input from all concerned stakeholders: regulatory bodies, academia, the pharmaceutical industry, parents and policymakers.

    The CDDF Paediatric Platform was created after the 2013 conference to intensify cooperation between all stakeholders and to make proposals that will address identified bottlenecks. Four working groups have been set up. At the 2015 conference, the working groups will report on their advances and their proposals will be discussed with all participants.

    The main goal of the conference is:

    • To define how to prioritize oncology drugs for their development in children and adolescents in order to increase and speed up access to innovative therapies for all patients
    • To increase the likelihood of developing effective treatments
    • To improve efficiency of development plans

    More information

    ENCCA General Assembly 2015

    15-16 January 2015, Brussels, Belgium

    Joining Efforts for a Brighter Future for Children and Adolescents with Cancer

    The European Roadmap to Horizon 2020

    18-19 September 2014, Brussels, Belgium (Renaissance Brussels Hotel)


     Introduction to ENCCA